

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.54508888 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.54508888 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.31744600 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.31744600 |
| 5 | glyoxylate metabolic process (GO:0046487) | 5.80887423 |
| 6 | lysine catabolic process (GO:0006554) | 5.80067966 |
| 7 | lysine metabolic process (GO:0006553) | 5.80067966 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 5.72880339 |
| 9 | alpha-linolenic acid metabolic process (GO:0036109) | 5.19842206 |
| 10 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.12992413 |
| 11 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.11599056 |
| 12 | kynurenine metabolic process (GO:0070189) | 5.06081889 |
| 13 | indole-containing compound catabolic process (GO:0042436) | 5.02189622 |
| 14 | indolalkylamine catabolic process (GO:0046218) | 5.02189622 |
| 15 | tryptophan catabolic process (GO:0006569) | 5.02189622 |
| 16 | cysteine metabolic process (GO:0006534) | 4.92300338 |
| 17 | bile acid biosynthetic process (GO:0006699) | 4.88678509 |
| 18 | fatty acid beta-oxidation (GO:0006635) | 4.78753764 |
| 19 | tryptophan metabolic process (GO:0006568) | 4.78576943 |
| 20 | amino-acid betaine metabolic process (GO:0006577) | 4.74802763 |
| 21 | * cellular ketone body metabolic process (GO:0046950) | 4.69472017 |
| 22 | short-chain fatty acid metabolic process (GO:0046459) | 4.64450419 |
| 23 | sulfur amino acid catabolic process (GO:0000098) | 4.64392819 |
| 24 | 2-oxoglutarate metabolic process (GO:0006103) | 4.52413102 |
| 25 | epoxygenase P450 pathway (GO:0019373) | 4.47839697 |
| 26 | aspartate family amino acid catabolic process (GO:0009068) | 4.47387706 |
| 27 | fatty acid oxidation (GO:0019395) | 4.46308631 |
| 28 | acetyl-CoA metabolic process (GO:0006084) | 4.42871397 |
| 29 | fatty acid catabolic process (GO:0009062) | 4.40418361 |
| 30 | regulation of triglyceride catabolic process (GO:0010896) | 4.40212445 |
| 31 | serine family amino acid catabolic process (GO:0009071) | 4.39429203 |
| 32 | lipid oxidation (GO:0034440) | 4.37743949 |
| 33 | urea cycle (GO:0000050) | 4.31341535 |
| 34 | urea metabolic process (GO:0019627) | 4.31341535 |
| 35 | alpha-amino acid catabolic process (GO:1901606) | 4.27527210 |
| 36 | omega-hydroxylase P450 pathway (GO:0097267) | 4.27183239 |
| 37 | homocysteine metabolic process (GO:0050667) | 4.23515600 |
| 38 | monocarboxylic acid catabolic process (GO:0072329) | 4.22907781 |
| 39 | high-density lipoprotein particle remodeling (GO:0034375) | 4.20473982 |
| 40 | aromatic amino acid family metabolic process (GO:0009072) | 4.19983082 |
| 41 | bile acid metabolic process (GO:0008206) | 4.10779859 |
| 42 | negative regulation of fibrinolysis (GO:0051918) | 4.10198874 |
| 43 | fatty acid transmembrane transport (GO:1902001) | 4.08906692 |
| 44 | tyrosine metabolic process (GO:0006570) | 4.05559957 |
| 45 | carnitine metabolic process (GO:0009437) | 4.05518757 |
| 46 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.05050400 |
| 47 | protein carboxylation (GO:0018214) | 4.05050400 |
| 48 | muscle filament sliding (GO:0030049) | 4.04852574 |
| 49 | actin-myosin filament sliding (GO:0033275) | 4.04852574 |
| 50 | coenzyme catabolic process (GO:0009109) | 4.03798058 |
| 51 | * cellular amino acid catabolic process (GO:0009063) | 4.03609013 |
| 52 | nitrogen cycle metabolic process (GO:0071941) | 4.01587244 |
| 53 | * ketone body metabolic process (GO:1902224) | 4.01425269 |
| 54 | valine metabolic process (GO:0006573) | 4.01262607 |
| 55 | regulation of fibrinolysis (GO:0051917) | 3.98199107 |
| 56 | drug transmembrane transport (GO:0006855) | 3.98035428 |
| 57 | acylglycerol homeostasis (GO:0055090) | 3.95266844 |
| 58 | triglyceride homeostasis (GO:0070328) | 3.95266844 |
| 59 | tricarboxylic acid cycle (GO:0006099) | 3.94517450 |
| 60 | complement activation, alternative pathway (GO:0006957) | 3.94353650 |
| 61 | carnitine shuttle (GO:0006853) | 3.94252199 |
| 62 | * organic acid catabolic process (GO:0016054) | 3.90877782 |
| 63 | * carboxylic acid catabolic process (GO:0046395) | 3.90877782 |
| 64 | * branched-chain amino acid catabolic process (GO:0009083) | 3.89966427 |
| 65 | cellular modified amino acid catabolic process (GO:0042219) | 3.87539100 |
| 66 | ethanol oxidation (GO:0006069) | 3.87333367 |
| 67 | drug catabolic process (GO:0042737) | 3.84442682 |
| 68 | regulation of protein activation cascade (GO:2000257) | 3.83697479 |
| 69 | glutamate metabolic process (GO:0006536) | 3.83304798 |
| 70 | tricarboxylic acid metabolic process (GO:0072350) | 3.81328612 |
| 71 | urate metabolic process (GO:0046415) | 3.79311820 |
| 72 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.79241547 |
| 73 | regulation of hexokinase activity (GO:1903299) | 3.79080817 |
| 74 | regulation of glucokinase activity (GO:0033131) | 3.79080817 |
| 75 | * branched-chain amino acid metabolic process (GO:0009081) | 3.75187677 |
| 76 | reverse cholesterol transport (GO:0043691) | 3.72128467 |
| 77 | protein-lipid complex remodeling (GO:0034368) | 3.69022430 |
| 78 | macromolecular complex remodeling (GO:0034367) | 3.69022430 |
| 79 | plasma lipoprotein particle remodeling (GO:0034369) | 3.69022430 |
| 80 | oxidative demethylation (GO:0070989) | 3.68469586 |
| 81 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.68009934 |
| 82 | regulation of cholesterol esterification (GO:0010872) | 3.67531218 |
| 83 | fatty acid homeostasis (GO:0055089) | 3.67336371 |
| 84 | succinate metabolic process (GO:0006105) | 3.65545920 |
| 85 | plasma lipoprotein particle clearance (GO:0034381) | 3.64344943 |
| 86 | indolalkylamine metabolic process (GO:0006586) | 3.60218111 |
| 87 | benzene-containing compound metabolic process (GO:0042537) | 3.58714069 |
| 88 | serine family amino acid metabolic process (GO:0009069) | 3.58043991 |
| 89 | positive regulation of fatty acid oxidation (GO:0046321) | 3.57672564 |
| 90 | regulation of complement activation (GO:0030449) | 3.56912667 |
| 91 | positive regulation of lipid catabolic process (GO:0050996) | 3.53559947 |
| 92 | biotin metabolic process (GO:0006768) | 3.53129357 |
| 93 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.52836175 |
| 94 | oxaloacetate metabolic process (GO:0006107) | 3.49406170 |
| 95 | cellular glucuronidation (GO:0052695) | 3.46814186 |
| 96 | phospholipid homeostasis (GO:0055091) | 3.46526495 |
| 97 | creatine metabolic process (GO:0006600) | 3.45697634 |
| 98 | L-methionine salvage (GO:0071267) | 3.45683125 |
| 99 | L-methionine biosynthetic process (GO:0071265) | 3.45683125 |
| 100 | amino acid salvage (GO:0043102) | 3.45683125 |
| 101 | NADH metabolic process (GO:0006734) | 3.45616823 |
| 102 | drug metabolic process (GO:0017144) | 3.45090428 |
| 103 | regulation of sequestering of triglyceride (GO:0010889) | 3.44749756 |
| 104 | aldehyde catabolic process (GO:0046185) | 3.44135227 |
| 105 | regulation of fatty acid oxidation (GO:0046320) | 3.42275796 |
| 106 | phospholipid efflux (GO:0033700) | 3.41395996 |
| 107 | negative regulation of sterol transport (GO:0032372) | 3.39659389 |
| 108 | negative regulation of cholesterol transport (GO:0032375) | 3.39659389 |
| 109 | cellular biogenic amine catabolic process (GO:0042402) | 3.38247871 |
| 110 | amine catabolic process (GO:0009310) | 3.38247871 |
| 111 | carnitine transport (GO:0015879) | 3.37691003 |
| 112 | amino-acid betaine transport (GO:0015838) | 3.37691003 |
| 113 | glucuronate metabolic process (GO:0019585) | 3.37666965 |
| 114 | uronic acid metabolic process (GO:0006063) | 3.37666965 |
| 115 | xenobiotic catabolic process (GO:0042178) | 3.36571065 |
| 116 | exogenous drug catabolic process (GO:0042738) | 3.36267305 |
| 117 | glycine metabolic process (GO:0006544) | 3.33535422 |
| 118 | blood coagulation, intrinsic pathway (GO:0007597) | 3.32798835 |
| 119 | actin-mediated cell contraction (GO:0070252) | 3.32096063 |
| 120 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.27214723 |
| 121 | phenylpropanoid metabolic process (GO:0009698) | 3.25694932 |
| 122 | fructose metabolic process (GO:0006000) | 3.19556070 |
| 123 | positive regulation of glycolytic process (GO:0045821) | 3.18179091 |
| 124 | oxidative phosphorylation (GO:0006119) | 3.16921576 |
| 125 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.16047043 |
| 126 | regulation of relaxation of muscle (GO:1901077) | 3.15708689 |
| 127 | regulation of skeletal muscle contraction (GO:0014819) | 3.13451430 |
| 128 | respiratory electron transport chain (GO:0022904) | 3.12795305 |
| 129 | glycogen catabolic process (GO:0005980) | 3.07955265 |
| 130 | S-adenosylmethionine metabolic process (GO:0046500) | 3.07537774 |
| 131 | gluconeogenesis (GO:0006094) | 3.06686814 |
| 132 | electron transport chain (GO:0022900) | 3.04778413 |
| 133 | response to mercury ion (GO:0046689) | 2.96274113 |
| 134 | negative regulation of protein activation cascade (GO:2000258) | 2.96266302 |
| 135 | fibrinolysis (GO:0042730) | 2.96038439 |
| 136 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.95758171 |
| 137 | ethanol metabolic process (GO:0006067) | 2.91476300 |
| 138 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.89964575 |
| 139 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.89845587 |
| 140 | hexose biosynthetic process (GO:0019319) | 2.87403561 |
| 141 | polyketide metabolic process (GO:0030638) | 2.82287603 |
| 142 | doxorubicin metabolic process (GO:0044598) | 2.82287603 |
| 143 | daunorubicin metabolic process (GO:0044597) | 2.82287603 |
| 144 | methionine biosynthetic process (GO:0009086) | 2.81056615 |
| 145 | skeletal muscle contraction (GO:0003009) | 2.76471237 |
| 146 | carnitine transmembrane transport (GO:1902603) | 2.76452190 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.25316816 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 7.05247533 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.20555575 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.66607693 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.22212696 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.60275534 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.94909328 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.67105616 |
| 9 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.35031465 |
| 10 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.33594762 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.98346845 |
| 12 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.27715286 |
| 13 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.22835979 |
| 14 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.18113313 |
| 15 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.14328567 |
| 16 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.11212866 |
| 17 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.08957563 |
| 18 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.3555105 |
| 19 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.97750297 |
| 20 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.92639796 |
| 21 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.89890100 |
| 22 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.83050833 |
| 23 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.78253915 |
| 24 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.73506624 |
| 25 | VDR_22108803_ChIP-Seq_LS180_Human | 1.69200590 |
| 26 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.61064174 |
| 27 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.54068484 |
| 28 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.50959319 |
| 29 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.50388049 |
| 30 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.44699581 |
| 31 | GATA1_22025678_ChIP-Seq_K562_Human | 1.44649802 |
| 32 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.44466796 |
| 33 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.39425375 |
| 34 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.36981553 |
| 35 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.35593284 |
| 36 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.32450168 |
| 37 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.31480716 |
| 38 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.30463668 |
| 39 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.28485000 |
| 40 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.27518106 |
| 41 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.26590617 |
| 42 | * FUS_26573619_Chip-Seq_HEK293_Human | 1.26555100 |
| 43 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.25411591 |
| 44 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.24770715 |
| 45 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.21033071 |
| 46 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.20893104 |
| 47 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.20382064 |
| 48 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.20179224 |
| 49 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.19674562 |
| 50 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.18855690 |
| 51 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.18048783 |
| 52 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.17287830 |
| 53 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.15352062 |
| 54 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.15182152 |
| 55 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.14731016 |
| 56 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.12462251 |
| 57 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.12319899 |
| 58 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.09922088 |
| 59 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.09268536 |
| 60 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.08959499 |
| 61 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.08495183 |
| 62 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.07852198 |
| 63 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.06308238 |
| 64 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.05487783 |
| 65 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.04885099 |
| 66 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.03021279 |
| 67 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.01402289 |
| 68 | NFYB_21822215_ChIP-Seq_K562_Human | 1.01068892 |
| 69 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.00278059 |
| 70 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.00269063 |
| 71 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.00205584 |
| 72 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.00046447 |
| 73 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.98432040 |
| 74 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.97961881 |
| 75 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.97114732 |
| 76 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.97042237 |
| 77 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.96661651 |
| 78 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.96340711 |
| 79 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.95920534 |
| 80 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.95626777 |
| 81 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.94542328 |
| 82 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.94434533 |
| 83 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.94384976 |
| 84 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.94200493 |
| 85 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.93622708 |
| 86 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.93078326 |
| 87 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.93078326 |
| 88 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.92259024 |
| 89 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.91883991 |
| 90 | NFYA_21822215_ChIP-Seq_K562_Human | 0.91857118 |
| 91 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.89829690 |
| 92 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.89275652 |
| 93 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.89271948 |
| 94 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.89255269 |
| 95 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.88995823 |
| 96 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.88744775 |
| 97 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.85833039 |
| 98 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.85833039 |
| 99 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.84318926 |
| 100 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.83161515 |
| 101 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.82284463 |
| 102 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.81172167 |
| 103 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.77254609 |
| 104 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.76522977 |
| 105 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.75522403 |
| 106 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.71485076 |
| 107 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.70592294 |
| 108 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.68078492 |
| 109 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.67252148 |
| 110 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.67100585 |
| 111 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.66403362 |
| 112 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.65685143 |
| 113 | AR_20517297_ChIP-Seq_VCAP_Human | 0.65056058 |
| 114 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.63701246 |
| 115 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.63577066 |
| 116 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.62441227 |
| 117 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.62231905 |
| 118 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.62099960 |
| 119 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.60904622 |
| 120 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.60847496 |
| 121 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.60701625 |
| 122 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.60093172 |
| 123 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.59823972 |
| 124 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.59645134 |
| 125 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.57820612 |
| 126 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.57801556 |
| 127 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.56917477 |
| 128 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.54137567 |
| 129 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.53169929 |
| 130 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.51982080 |
| 131 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.51434449 |
| 132 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.49709994 |
| 133 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.49611002 |
| 134 | * CBP_20019798_ChIP-Seq_JUKART_Human | 0.49165610 |
| 135 | * IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.49165610 |
| 136 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.48601353 |
| 137 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.48530784 |
| 138 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.48166594 |
| 139 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.48007066 |
| 140 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.47289001 |
| 141 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.47289001 |
| 142 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.47012923 |
| 143 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.46632978 |
| 144 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.45527150 |
| 145 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.45202200 |
| 146 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.45173211 |
| 147 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.45090243 |
| 148 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.44464955 |
| 149 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.44251265 |
| 150 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.43944343 |
| 151 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.43841180 |
| 152 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.43785544 |
| 153 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.43461917 |
| 154 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.43390409 |
| 155 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.43300204 |
| 156 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.43276419 |
| 157 | * GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.43263536 |
| 158 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.43230733 |
| 159 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.43079466 |
| 160 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.42879510 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.24380758 |
| 2 | MP0005360_urolithiasis | 6.78959162 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.51174811 |
| 4 | MP0005365_abnormal_bile_salt | 5.37638050 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.28786713 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.54462571 |
| 7 | MP0003252_abnormal_bile_duct | 3.38616080 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.20234825 |
| 9 | MP0004145_abnormal_muscle_electrophysio | 3.14032356 |
| 10 | MP0005332_abnormal_amino_acid | 3.08367407 |
| 11 | MP0002837_dystrophic_cardiac_calcinosis | 3.05644837 |
| 12 | MP0003195_calcinosis | 3.00964800 |
| 13 | MP0005083_abnormal_biliary_tract | 2.41429875 |
| 14 | MP0009840_abnormal_foam_cell | 2.35473229 |
| 15 | MP0001666_abnormal_nutrient_absorption | 2.34061176 |
| 16 | MP0002118_abnormal_lipid_homeostasis | 2.13808276 |
| 17 | MP0004019_abnormal_vitamin_homeostasis | 2.09719891 |
| 18 | MP0004130_abnormal_muscle_cell | 2.05515236 |
| 19 | MP0000372_irregular_coat_pigmentation | 2.05066834 |
| 20 | MP0003191_abnormal_cellular_cholesterol | 2.03235128 |
| 21 | MP0003646_muscle_fatigue | 1.94123617 |
| 22 | MP0006036_abnormal_mitochondrial_physio | 1.90945376 |
| 23 | MP0000609_abnormal_liver_physiology | 1.86550405 |
| 24 | MP0002138_abnormal_hepatobiliary_system | 1.83748010 |
| 25 | MP0005319_abnormal_enzyme/_coenzyme | 1.80575287 |
| 26 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.74948078 |
| 27 | MP0005670_abnormal_white_adipose | 1.72918710 |
| 28 | MP0009643_abnormal_urine_homeostasis | 1.65869738 |
| 29 | MP0010234_abnormal_vibrissa_follicle | 1.58798074 |
| 30 | MP0001764_abnormal_homeostasis | 1.55326521 |
| 31 | MP0004043_abnormal_pH_regulation | 1.54567726 |
| 32 | MP0003868_abnormal_feces_composition | 1.49303916 |
| 33 | MP0005451_abnormal_body_composition | 1.48510695 |
| 34 | MP0003950_abnormal_plasma_membrane | 1.43558589 |
| 35 | MP0000759_abnormal_skeletal_muscle | 1.40776375 |
| 36 | MP0004233_abnormal_muscle_weight | 1.37552374 |
| 37 | MP0005330_cardiomyopathy | 1.35465446 |
| 38 | MP0005369_muscle_phenotype | 1.35399635 |
| 39 | MP0005666_abnormal_adipose_tissue | 1.33731936 |
| 40 | MP0004215_abnormal_myocardial_fiber | 1.33512060 |
| 41 | MP0005187_abnormal_penis_morphology | 1.33309003 |
| 42 | MP0003186_abnormal_redox_activity | 1.27748300 |
| 43 | MP0005636_abnormal_mineral_homeostasis | 1.27389648 |
| 44 | MP0005535_abnormal_body_temperature | 1.27241725 |
| 45 | MP0000751_myopathy | 1.26459795 |
| 46 | MP0002971_abnormal_brown_adipose | 1.22275538 |
| 47 | MP0005379_endocrine/exocrine_gland_phen | 1.20410596 |
| 48 | MP0004036_abnormal_muscle_relaxation | 1.20165942 |
| 49 | MP0002078_abnormal_glucose_homeostasis | 1.17730147 |
| 50 | MP0002876_abnormal_thyroid_physiology | 1.17341981 |
| 51 | MP0004084_abnormal_cardiac_muscle | 1.16572866 |
| 52 | MP0009697_abnormal_copulation | 1.15737024 |
| 53 | MP0006035_abnormal_mitochondrial_morpho | 1.10076539 |
| 54 | MP0001756_abnormal_urination | 1.03486210 |
| 55 | MP0003656_abnormal_erythrocyte_physiolo | 0.95353573 |
| 56 | MP0000003_abnormal_adipose_tissue | 0.94220670 |
| 57 | MP0002638_abnormal_pupillary_reflex | 0.94214911 |
| 58 | MP0005084_abnormal_gallbladder_morpholo | 0.93705575 |
| 59 | MP0002090_abnormal_vision | 0.92282929 |
| 60 | MP0005334_abnormal_fat_pad | 0.92262632 |
| 61 | MP0000598_abnormal_liver_morphology | 0.92216152 |
| 62 | MP0003718_maternal_effect | 0.91276006 |
| 63 | MP0010368_abnormal_lymphatic_system | 0.90782758 |
| 64 | MP0003011_delayed_dark_adaptation | 0.89653219 |
| 65 | MP0000230_abnormal_systemic_arterial | 0.87560019 |
| 66 | MP0009642_abnormal_blood_homeostasis | 0.87334075 |
| 67 | MP0002972_abnormal_cardiac_muscle | 0.86066884 |
| 68 | MP0000750_abnormal_muscle_regeneration | 0.85572633 |
| 69 | MP0000749_muscle_degeneration | 0.85253942 |
| 70 | MP0005620_abnormal_muscle_contractility | 0.82456943 |
| 71 | MP0001944_abnormal_pancreas_morphology | 0.82443006 |
| 72 | MP0005645_abnormal_hypothalamus_physiol | 0.82115431 |
| 73 | MP0000604_amyloidosis | 0.82081854 |
| 74 | MP0002269_muscular_atrophy | 0.81783721 |
| 75 | MP0003221_abnormal_cardiomyocyte_apopto | 0.79776853 |
| 76 | MP0001544_abnormal_cardiovascular_syste | 0.79309809 |
| 77 | MP0005385_cardiovascular_system_phenoty | 0.79309809 |
| 78 | MP0004087_abnormal_muscle_fiber | 0.79166303 |
| 79 | MP0008775_abnormal_heart_ventricle | 0.78256190 |
| 80 | MP0001765_abnormal_ion_homeostasis | 0.77755267 |
| 81 | MP0003705_abnormal_hypodermis_morpholog | 0.77698928 |
| 82 | MP0001661_extended_life_span | 0.77576196 |
| 83 | MP0005266_abnormal_metabolism | 0.77167217 |
| 84 | MP0005220_abnormal_exocrine_pancreas | 0.76030357 |
| 85 | MP0005376_homeostasis/metabolism_phenot | 0.75200963 |
| 86 | MP0004185_abnormal_adipocyte_glucose | 0.75096435 |
| 87 | MP0005375_adipose_tissue_phenotype | 0.74270393 |
| 88 | MP0005448_abnormal_energy_balance | 0.73850104 |
| 89 | MP0006138_congestive_heart_failure | 0.73670998 |
| 90 | MP0005647_abnormal_sex_gland | 0.73042654 |
| 91 | MP0009763_increased_sensitivity_to | 0.72943386 |
| 92 | MP0003329_amyloid_beta_deposits | 0.72400291 |
| 93 | MP0001984_abnormal_olfaction | 0.70769144 |
| 94 | MP0003137_abnormal_impulse_conducting | 0.70524875 |
| 95 | MP0002127_abnormal_cardiovascular_syste | 0.69233609 |
| 96 | MP0002163_abnormal_gland_morphology | 0.68276232 |
| 97 | MP0002108_abnormal_muscle_morphology | 0.67494132 |
| 98 | MP0002693_abnormal_pancreas_physiology | 0.66986209 |
| 99 | MP0005395_other_phenotype | 0.66947028 |
| 100 | MP0000747_muscle_weakness | 0.66470181 |
| 101 | MP0003953_abnormal_hormone_level | 0.65957076 |
| 102 | MP0009764_decreased_sensitivity_to | 0.65943948 |
| 103 | MP0005452_abnormal_adipose_tissue | 0.64886009 |
| 104 | MP0005408_hypopigmentation | 0.64452862 |
| 105 | MP0002822_catalepsy | 0.64119759 |
| 106 | MP0004147_increased_porphyrin_level | 0.62238353 |
| 107 | MP0005551_abnormal_eye_electrophysiolog | 0.61606628 |
| 108 | MP0003136_yellow_coat_color | 0.61078722 |
| 109 | MP0002136_abnormal_kidney_physiology | 0.60763385 |
| 110 | MP0006072_abnormal_retinal_apoptosis | 0.60366210 |
| 111 | MP0008469_abnormal_protein_level | 0.59995404 |
| 112 | MP0004085_abnormal_heartbeat | 0.57455640 |
| 113 | MP0010630_abnormal_cardiac_muscle | 0.55914808 |
| 114 | MP0009115_abnormal_fat_cell | 0.53962589 |
| 115 | MP0003690_abnormal_glial_cell | 0.53659499 |
| 116 | MP0002970_abnormal_white_adipose | 0.53030735 |
| 117 | MP0000013_abnormal_adipose_tissue | 0.52909759 |
| 118 | MP0003959_abnormal_lean_body | 0.52086387 |
| 119 | MP0004484_altered_response_of | 0.51668066 |
| 120 | MP0002332_abnormal_exercise_endurance | 0.46054663 |
| 121 | MP0002909_abnormal_adrenal_gland | 0.46005808 |
| 122 | MP0009780_abnormal_chondrocyte_physiolo | 0.45613492 |
| 123 | MP0002106_abnormal_muscle_physiology | 0.43363550 |
| 124 | MP0000538_abnormal_urinary_bladder | 0.42646044 |
| 125 | MP0009765_abnormal_xenobiotic_induced | 0.41946028 |
| 126 | MP0008874_decreased_physiological_sensi | 0.41896961 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.66825247 |
| 2 | Nemaline bodies (HP:0003798) | 5.33008797 |
| 3 | Muscle fiber inclusion bodies (HP:0100299) | 5.28504288 |
| 4 | Intrahepatic cholestasis (HP:0001406) | 5.20750657 |
| 5 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.12408641 |
| 6 | Deep venous thrombosis (HP:0002625) | 5.09272002 |
| 7 | Xanthomatosis (HP:0000991) | 4.82193213 |
| 8 | Hypoglycemic coma (HP:0001325) | 4.81812671 |
| 9 | * Ketosis (HP:0001946) | 4.72399506 |
| 10 | Hyperglycinuria (HP:0003108) | 4.69953603 |
| 11 | Hyperammonemia (HP:0001987) | 4.69434883 |
| 12 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.55359266 |
| 13 | Abnormality of glycine metabolism (HP:0010895) | 4.40391921 |
| 14 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.40391921 |
| 15 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.33417635 |
| 16 | Prolonged partial thromboplastin time (HP:0003645) | 4.33177999 |
| 17 | Exercise-induced muscle cramps (HP:0003710) | 4.29976039 |
| 18 | Hypobetalipoproteinemia (HP:0003563) | 4.29142622 |
| 19 | Hyperglycinemia (HP:0002154) | 4.18643704 |
| 20 | * Ketoacidosis (HP:0001993) | 4.16466041 |
| 21 | Hyperlipoproteinemia (HP:0010980) | 4.12770596 |
| 22 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.85014262 |
| 23 | Dicarboxylic aciduria (HP:0003215) | 3.79534743 |
| 24 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.79534743 |
| 25 | Calf muscle hypertrophy (HP:0008981) | 3.74859837 |
| 26 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.73076710 |
| 27 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.70903199 |
| 28 | Generalized aminoaciduria (HP:0002909) | 3.69646148 |
| 29 | Hypolipoproteinemia (HP:0010981) | 3.65794840 |
| 30 | Hypoalphalipoproteinemia (HP:0003233) | 3.57266109 |
| 31 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.56646004 |
| 32 | Cerebral edema (HP:0002181) | 3.52679260 |
| 33 | Gout (HP:0001997) | 3.45032387 |
| 34 | Complement deficiency (HP:0004431) | 3.44613928 |
| 35 | Type 1 muscle fiber predominance (HP:0003803) | 3.43218400 |
| 36 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.37599609 |
| 37 | Epidermoid cyst (HP:0200040) | 3.36613541 |
| 38 | Metabolic acidosis (HP:0001942) | 3.29682771 |
| 39 | EMG: myopathic abnormalities (HP:0003458) | 3.24287105 |
| 40 | Proximal tubulopathy (HP:0000114) | 3.18518648 |
| 41 | Lethargy (HP:0001254) | 3.17084593 |
| 42 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.17013155 |
| 43 | Myoglobinuria (HP:0002913) | 3.16880450 |
| 44 | Abnormality of serum amino acid levels (HP:0003112) | 3.10826115 |
| 45 | Hepatic necrosis (HP:0002605) | 3.10182557 |
| 46 | Abnormality of purine metabolism (HP:0004352) | 3.07504943 |
| 47 | Joint hemorrhage (HP:0005261) | 3.06564405 |
| 48 | Abnormality of methionine metabolism (HP:0010901) | 3.03345366 |
| 49 | Abnormality of the common coagulation pathway (HP:0010990) | 3.00870252 |
| 50 | Abnormality of the calf musculature (HP:0001430) | 2.99326998 |
| 51 | Delayed CNS myelination (HP:0002188) | 2.93769678 |
| 52 | Acute encephalopathy (HP:0006846) | 2.91043081 |
| 53 | Fat malabsorption (HP:0002630) | 2.88303609 |
| 54 | Abnormality of the intrinsic pathway (HP:0010989) | 2.76987656 |
| 55 | Abnormality of nucleobase metabolism (HP:0010932) | 2.76681521 |
| 56 | Bundle branch block (HP:0011710) | 2.75613576 |
| 57 | Hyperbilirubinemia (HP:0002904) | 2.70687096 |
| 58 | * Vomiting (HP:0002013) | 2.68177490 |
| 59 | Abnormality of urine glucose concentration (HP:0011016) | 2.64929463 |
| 60 | Glycosuria (HP:0003076) | 2.64929463 |
| 61 | Hyperuricemia (HP:0002149) | 2.64036572 |
| 62 | Increased purine levels (HP:0004368) | 2.64036572 |
| 63 | Hyporeflexia of lower limbs (HP:0002600) | 2.60972024 |
| 64 | Rimmed vacuoles (HP:0003805) | 2.60251121 |
| 65 | Conjugated hyperbilirubinemia (HP:0002908) | 2.58486432 |
| 66 | Reduced antithrombin III activity (HP:0001976) | 2.57448509 |
| 67 | Hypercholesterolemia (HP:0003124) | 2.50927146 |
| 68 | Subaortic stenosis (HP:0001682) | 2.50641298 |
| 69 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.50641298 |
| 70 | Abnormality of glycolysis (HP:0004366) | 2.50364467 |
| 71 | Increased serum pyruvate (HP:0003542) | 2.50364467 |
| 72 | Skin nodule (HP:0200036) | 2.48012024 |
| 73 | Increased muscle lipid content (HP:0009058) | 2.46992468 |
| 74 | Hyperalaninemia (HP:0003348) | 2.45842567 |
| 75 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.45842567 |
| 76 | Abnormality of alanine metabolism (HP:0010916) | 2.45842567 |
| 77 | Asymmetric septal hypertrophy (HP:0001670) | 2.44888513 |
| 78 | Rhabdomyolysis (HP:0003201) | 2.44826983 |
| 79 | Hypoglycemic seizures (HP:0002173) | 2.44356447 |
| 80 | Exercise intolerance (HP:0003546) | 2.44254053 |
| 81 | Late onset (HP:0003584) | 2.42960261 |
| 82 | Renal cortical cysts (HP:0000803) | 2.35066291 |
| 83 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.34693333 |
| 84 | Distal arthrogryposis (HP:0005684) | 2.33248926 |
| 85 | Neck muscle weakness (HP:0000467) | 2.32544473 |
| 86 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.32353858 |
| 87 | Nausea (HP:0002018) | 2.30510474 |
| 88 | Abnormality of complement system (HP:0005339) | 2.29488990 |
| 89 | Hepatocellular carcinoma (HP:0001402) | 2.29104204 |
| 90 | Exercise-induced myalgia (HP:0003738) | 2.28371414 |
| 91 | Muscle fiber splitting (HP:0003555) | 2.27037604 |
| 92 | Lipid accumulation in hepatocytes (HP:0006561) | 2.26668515 |
| 93 | Hepatocellular necrosis (HP:0001404) | 2.26344570 |
| 94 | Palpitations (HP:0001962) | 2.25586723 |
| 95 | Lactic acidosis (HP:0003128) | 2.24861913 |
| 96 | Heart block (HP:0012722) | 2.21281083 |
| 97 | Sensorimotor neuropathy (HP:0007141) | 2.21274376 |
| 98 | Abnormal gallbladder morphology (HP:0012437) | 2.20856769 |
| 99 | Increased serum lactate (HP:0002151) | 2.20614813 |
| 100 | Cholelithiasis (HP:0001081) | 2.20381689 |
| 101 | Neonatal onset (HP:0003623) | 2.19368807 |
| 102 | Acute necrotizing encephalopathy (HP:0006965) | 2.18370074 |
| 103 | Increased hepatocellular lipid droplets (HP:0006565) | 2.16234352 |
| 104 | Myopathic facies (HP:0002058) | 2.16130686 |
| 105 | Dilated cardiomyopathy (HP:0001644) | 2.15931299 |
| 106 | Sudden death (HP:0001699) | 2.15670535 |
| 107 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.15034676 |
| 108 | Irritability (HP:0000737) | 2.11562514 |
| 109 | Methylmalonic aciduria (HP:0012120) | 2.11158084 |
| 110 | Alkalosis (HP:0001948) | 2.10233625 |
| 111 | Respiratory failure (HP:0002878) | 2.06850481 |
| 112 | Atrioventricular block (HP:0001678) | 2.05567173 |
| 113 | Abnormal atrioventricular conduction (HP:0005150) | 2.05358420 |
| 114 | Conjunctival hamartoma (HP:0100780) | 2.04399551 |
| 115 | Pancreatitis (HP:0001733) | 2.03931778 |
| 116 | Hyperglycemia (HP:0003074) | 2.03789955 |
| 117 | Steatorrhea (HP:0002570) | 2.02889390 |
| 118 | Abnormality of proline metabolism (HP:0010907) | 2.02528195 |
| 119 | Hydroxyprolinuria (HP:0003080) | 2.02528195 |
| 120 | Large for gestational age (HP:0001520) | 2.02488759 |
| 121 | Enlarged kidneys (HP:0000105) | 2.01049202 |
| 122 | Ragged-red muscle fibers (HP:0003200) | 1.99984095 |
| 123 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.98963687 |
| 124 | Vascular calcification (HP:0004934) | 1.96974518 |
| 125 | 3-Methylglutaconic aciduria (HP:0003535) | 1.96240060 |
| 126 | Ventricular tachycardia (HP:0004756) | 1.96015190 |
| 127 | Renal Fanconi syndrome (HP:0001994) | 1.94973511 |
| 128 | Increased intramyocellular lipid droplets (HP:0012240) | 1.93861730 |
| 129 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.93782904 |
| 130 | Pheochromocytoma (HP:0002666) | 1.93708219 |
| 131 | Increased CSF lactate (HP:0002490) | 1.91147897 |
| 132 | Cholecystitis (HP:0001082) | 1.90861908 |
| 133 | Abnormal gallbladder physiology (HP:0012438) | 1.90861908 |
| 134 | Brushfield spots (HP:0001088) | 1.89709779 |
| 135 | Progressive macrocephaly (HP:0004481) | 1.88160320 |
| 136 | Spontaneous abortion (HP:0005268) | 1.85605302 |
| 137 | Mitochondrial inheritance (HP:0001427) | 1.83053024 |
| 138 | Malnutrition (HP:0004395) | 1.82703932 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.90236137 |
| 2 | PDK3 | 3.10049973 |
| 3 | PDK4 | 3.10049973 |
| 4 | TRIB3 | 2.99479478 |
| 5 | SIK1 | 2.89733020 |
| 6 | INSRR | 2.82675749 |
| 7 | WNK4 | 2.79321002 |
| 8 | PKN2 | 2.73885920 |
| 9 | EIF2AK1 | 2.71614571 |
| 10 | EIF2AK3 | 2.68103605 |
| 11 | FGFR4 | 2.41840311 |
| 12 | ERN1 | 2.41771199 |
| 13 | STK16 | 2.18661521 |
| 14 | LMTK2 | 2.13155195 |
| 15 | WNK3 | 2.05408257 |
| 16 | PHKG2 | 2.02239148 |
| 17 | PHKG1 | 2.02239148 |
| 18 | MAP2K4 | 2.00589121 |
| 19 | MYLK | 1.93060116 |
| 20 | OBSCN | 1.90866556 |
| 21 | PINK1 | 1.79682065 |
| 22 | TTN | 1.68881783 |
| 23 | NEK1 | 1.68475804 |
| 24 | PDK2 | 1.60713958 |
| 25 | OXSR1 | 1.57684148 |
| 26 | LIMK1 | 1.55893977 |
| 27 | MAPKAPK3 | 1.54355378 |
| 28 | TIE1 | 1.53216548 |
| 29 | MST1R | 1.51997475 |
| 30 | FLT3 | 1.51007769 |
| 31 | PIK3CG | 1.48221754 |
| 32 | BUB1 | 1.45565951 |
| 33 | TRPM7 | 1.43310937 |
| 34 | MST4 | 1.42442973 |
| 35 | ERBB4 | 1.31975373 |
| 36 | ERBB3 | 1.29388717 |
| 37 | BMPR1B | 1.26904718 |
| 38 | PRKAA2 | 1.26718962 |
| 39 | PIK3CA | 1.25607577 |
| 40 | TAOK3 | 1.24160363 |
| 41 | NEK9 | 1.23230848 |
| 42 | PBK | 1.21741060 |
| 43 | SCYL2 | 1.19549285 |
| 44 | STK38L | 1.16370429 |
| 45 | MAP3K7 | 1.12753111 |
| 46 | MAPK11 | 1.09486680 |
| 47 | FRK | 1.08770446 |
| 48 | CCNB1 | 1.07708778 |
| 49 | ZAK | 1.05961051 |
| 50 | MAP3K9 | 1.03447019 |
| 51 | MAP3K12 | 1.02819332 |
| 52 | PRKAA1 | 0.99448150 |
| 53 | MAPK12 | 0.99370792 |
| 54 | PAK3 | 0.98896926 |
| 55 | MAP4K2 | 0.98534681 |
| 56 | STK39 | 0.97930049 |
| 57 | SGK223 | 0.91374797 |
| 58 | SGK494 | 0.91374797 |
| 59 | ABL2 | 0.87819014 |
| 60 | MAP3K4 | 0.85797397 |
| 61 | DAPK2 | 0.84805209 |
| 62 | SGK2 | 0.79991678 |
| 63 | GRK7 | 0.78958632 |
| 64 | VRK2 | 0.76977850 |
| 65 | AKT2 | 0.75501765 |
| 66 | SGK3 | 0.74648599 |
| 67 | PLK3 | 0.74271882 |
| 68 | PRKACG | 0.73353111 |
| 69 | PTK6 | 0.72108237 |
| 70 | TSSK6 | 0.72049398 |
| 71 | RIPK1 | 0.70367706 |
| 72 | KDR | 0.70239275 |
| 73 | MUSK | 0.69031705 |
| 74 | TNIK | 0.68652883 |
| 75 | MAPKAPK5 | 0.68591408 |
| 76 | LATS1 | 0.67620723 |
| 77 | CAMK1D | 0.67427489 |
| 78 | JAK2 | 0.67113570 |
| 79 | MARK1 | 0.66341373 |
| 80 | BRSK2 | 0.64454539 |
| 81 | MAP2K3 | 0.64302879 |
| 82 | MAPK4 | 0.63856486 |
| 83 | MAP3K6 | 0.63731135 |
| 84 | PDPK1 | 0.63717563 |
| 85 | AKT3 | 0.61760183 |
| 86 | GRK1 | 0.61746431 |
| 87 | TESK1 | 0.61380595 |
| 88 | PLK4 | 0.60814145 |
| 89 | EEF2K | 0.60342699 |
| 90 | EPHA3 | 0.60243270 |
| 91 | NME1 | 0.60109673 |
| 92 | MAP2K7 | 0.58798685 |
| 93 | MAPK15 | 0.58644609 |
| 94 | CSNK1G1 | 0.58615624 |
| 95 | MAP2K1 | 0.57835740 |
| 96 | CSNK1G3 | 0.57810491 |
| 97 | RET | 0.56869895 |
| 98 | DMPK | 0.56690926 |
| 99 | NME2 | 0.56613941 |
| 100 | PRKG1 | 0.56588809 |
| 101 | EPHA4 | 0.56507427 |
| 102 | STK24 | 0.56343414 |
| 103 | CAMK2G | 0.55889886 |
| 104 | ACVR1B | 0.55273216 |
| 105 | PRKCZ | 0.54999199 |
| 106 | TTK | 0.54821990 |
| 107 | MAP3K5 | 0.53651873 |
| 108 | MAP3K2 | 0.53464430 |
| 109 | VRK1 | 0.52780596 |
| 110 | FGFR2 | 0.52447050 |
| 111 | EIF2AK2 | 0.49102789 |
| 112 | PRKD1 | 0.48990491 |
| 113 | NTRK3 | 0.48880172 |
| 114 | PDK1 | 0.48253626 |
| 115 | GSK3A | 0.45785469 |
| 116 | STK3 | 0.45685845 |
| 117 | WEE1 | 0.45397958 |
| 118 | CSNK2A2 | 0.44631873 |
| 119 | MAP3K3 | 0.44255366 |
| 120 | ARAF | 0.44142070 |
| 121 | MAP2K6 | 0.44077620 |
| 122 | PLK1 | 0.43874268 |
| 123 | PRKACA | 0.43318926 |
| 124 | NUAK1 | 0.42514516 |
| 125 | DYRK1B | 0.42154660 |
| 126 | PLK2 | 0.41458400 |
| 127 | PKN1 | 0.40746145 |
| 128 | TGFBR2 | 0.40438880 |
| 129 | JAK1 | 0.40066205 |
| 130 | CAMK2A | 0.39515396 |
| 131 | RPS6KB2 | 0.38754893 |
| 132 | ILK | 0.38743374 |
| 133 | CSNK1G2 | 0.38304789 |
| 134 | PNCK | 0.37611291 |
| 135 | CAMK4 | 0.37287815 |
| 136 | CAMK2D | 0.37230270 |
| 137 | PRKACB | 0.37064763 |
| 138 | CSNK1E | 0.36305115 |
| 139 | STK4 | 0.35814406 |
| 140 | FGFR3 | 0.35549663 |
| 141 | CAMK1G | 0.34617151 |
| 142 | CDK3 | 0.33152283 |
| 143 | PRKCH | 0.30952536 |
| 144 | CSNK2A1 | 0.29540686 |
| 145 | PRKCG | 0.29492765 |
| 146 | ROCK1 | 0.28506537 |
| 147 | CSNK1A1L | 0.28468639 |
| 148 | EPHB1 | 0.28326110 |
| 149 | TYK2 | 0.28240361 |
| 150 | PRKCQ | 0.27172365 |
| 151 | IGF1R | 0.26879092 |
| 152 | FER | 0.25287559 |
| 153 | PRKCE | 0.23711828 |
| 154 | MET | 0.23182263 |
| 155 | STK38 | 0.20351950 |
| 156 | GRK6 | 0.20346993 |
| 157 | SGK1 | 0.20014160 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.47438848 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.18413191 |
| 3 | * Fatty acid degradation_Homo sapiens_hsa00071 | 3.16373930 |
| 4 | * Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.13925309 |
| 5 | * Propanoate metabolism_Homo sapiens_hsa00640 | 3.05564149 |
| 6 | * Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.90191559 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.81478877 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.72327275 |
| 9 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.70725231 |
| 10 | * Butanoate metabolism_Homo sapiens_hsa00650 | 2.68683641 |
| 11 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.66484528 |
| 12 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.63872513 |
| 13 | * Tryptophan metabolism_Homo sapiens_hsa00380 | 2.49609173 |
| 14 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.49102095 |
| 15 | * Fatty acid metabolism_Homo sapiens_hsa01212 | 2.45354535 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.21659275 |
| 17 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.13217867 |
| 18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.09602094 |
| 19 | * Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.02016209 |
| 20 | * Pyruvate metabolism_Homo sapiens_hsa00620 | 1.99040051 |
| 21 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.94744763 |
| 22 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.88678201 |
| 23 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.82158874 |
| 24 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.81506958 |
| 25 | * Carbon metabolism_Homo sapiens_hsa01200 | 1.74047128 |
| 26 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.64333756 |
| 27 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.59325922 |
| 28 | Histidine metabolism_Homo sapiens_hsa00340 | 1.48946987 |
| 29 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.45222566 |
| 30 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.44763412 |
| 31 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.44723290 |
| 32 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.39703980 |
| 33 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.37503985 |
| 34 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.35296395 |
| 35 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.31931783 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.28409818 |
| 37 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.27346791 |
| 38 | Protein export_Homo sapiens_hsa03060 | 1.27094342 |
| 39 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.26753973 |
| 40 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.26349610 |
| 41 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.22454337 |
| 42 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.22299672 |
| 43 | Retinol metabolism_Homo sapiens_hsa00830 | 1.18579849 |
| 44 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.12059930 |
| 45 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.11524290 |
| 46 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.10247208 |
| 47 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.06654802 |
| 48 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.05297459 |
| 49 | Proteasome_Homo sapiens_hsa03050 | 1.04860237 |
| 50 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.01483546 |
| 51 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.00842450 |
| 52 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.99524415 |
| 53 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.96733604 |
| 54 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.92622629 |
| 55 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.91923618 |
| 56 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.91272762 |
| 57 | ABC transporters_Homo sapiens_hsa02010 | 0.85779899 |
| 58 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.83398511 |
| 59 | Parkinsons disease_Homo sapiens_hsa05012 | 0.82330233 |
| 60 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.79885171 |
| 61 | * Lysine degradation_Homo sapiens_hsa00310 | 0.76552867 |
| 62 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.75718268 |
| 63 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.75533461 |
| 64 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.73351246 |
| 65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.72182292 |
| 66 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.71765509 |
| 67 | Sulfur relay system_Homo sapiens_hsa04122 | 0.66698098 |
| 68 | Circadian rhythm_Homo sapiens_hsa04710 | 0.65087166 |
| 69 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.62931713 |
| 70 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.56923856 |
| 71 | Alzheimers disease_Homo sapiens_hsa05010 | 0.56354358 |
| 72 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.53403701 |
| 73 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.52800865 |
| 74 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.51078182 |
| 75 | RNA polymerase_Homo sapiens_hsa03020 | 0.45774582 |
| 76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.44966706 |
| 77 | Purine metabolism_Homo sapiens_hsa00230 | 0.42833254 |
| 78 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.42717823 |
| 79 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.42440828 |
| 80 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.41421075 |
| 81 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.41230721 |
| 82 | Insulin resistance_Homo sapiens_hsa04931 | 0.41042243 |
| 83 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.39847016 |
| 84 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.35989155 |
| 85 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.33423491 |
| 86 | Galactose metabolism_Homo sapiens_hsa00052 | 0.32851154 |
| 87 | Huntingtons disease_Homo sapiens_hsa05016 | 0.30636132 |
| 88 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.27303713 |
| 89 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.25143900 |
| 90 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.23969315 |
| 91 | Insulin secretion_Homo sapiens_hsa04911 | 0.23128791 |
| 92 | Homologous recombination_Homo sapiens_hsa03440 | 0.22434523 |
| 93 | Mineral absorption_Homo sapiens_hsa04978 | 0.20624575 |
| 94 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.18272774 |
| 95 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.16986385 |
| 96 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.14716600 |
| 97 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.14029957 |
| 98 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.10214488 |
| 99 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.08947423 |
| 100 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.08502624 |
| 101 | Prion diseases_Homo sapiens_hsa05020 | 0.07358069 |
| 102 | * Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.03811734 |
| 103 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.01544704 |
| 104 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1278601 |
| 105 | Collecting duct acid secretion_Homo sapiens_hsa04966 | -0.1192504 |
| 106 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.1156946 |
| 107 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1105882 |
| 108 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1100381 |
| 109 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1088356 |
| 110 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1000410 |
| 111 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0925238 |
| 112 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0771913 |
| 113 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.0600744 |
| 114 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | -0.0398653 |
| 115 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | -0.0395634 |
| 116 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | -0.0286313 |

